NUCLEOLIN and glioma: Moreover, NCL was indeed present in the wall of tumor blood vessels, showing an increased expression during glial tumor progression (WHO I–IV; Figure 2, L–O), further suggesting a regulatory effect on human glial brain tumor angiogenesis.